NASOBOL

· Acerus Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NASOBOL, covering 2018-03-30 to 2018-03-30. Get the full timeline:

Most recent: Clinical Trial Update: NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers [Phase 1]